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Abstract Age related bone diseases such as osteoporosis
are considered among the main causes of reduced bone
mechanical stability and bone fractures. In order to restore
both biological and mechanical function of diseased/frac-
tured bones, novel bioactive scaffolds that mimic the bone
structure are constantly under development in tissue engi-
neering applications. Among the possible candidates, chi-
tosan-based thermosensitive hydrogel scaffolds represent
ideal systems due to their biocompatibility, biodegrad-
ability, enhanced antibacterial properties, promotion of
osteoblast formation and ease of injection, which makes
them suitable for less invasive surgical procedures. As a
main drawback, these chitosan systems present poor
mechanical performance that could not support load-bear-
ing applications. In order to produce more mechanically-
competent biomaterials, the combined addition of
hydroxyapatite and carbon nanotubes (CNTs) is proposed
in this study. Specifically, the aim of this work is to
develop thermosensitive chitosan hydrogels containing
stabilised single-walled and multi-walled CNTs, where
their effect on the mechanical/physiochemical properties,
calcium deposition patterns and ability to provide a plat-
form for the controlled release of protein drugs was
investigated. It was found that the addition of CNTs had a
significant effect on the sol–gel transition time and sig-
nificantly increased the resistance to compression for the
hydrogels. Moreover, in vitro calcification studies revealed
that CNTs played a major role in the spatial arrangements
of newly formed calcium deposits in the composite mate-
rials studied, suggesting that they may have a role in the
way the repair of fragile and/or fractured bones occurs
in vivo.
1 Introduction
Bone is a dynamic, mineralised and highly vascularised
tissue whose major functions are body support, motion and
organ protection. Major alterations in its structure, due to
injuries or metabolic diseases, can cause long-term pain,
infection, inflammation and loss of mobility that can lead
to a general decrease in functionality and quality of life [1].
Current therapies for complex bone fractures are mainly
based on auto- and allo-bone grafts, or on the use of inert
materials such as metals and ceramics that replace bone.
These invasive strategies have, however, many serious
limitations such as an inadequate revascularisation and
mineralisation of the bone grafts, risk of infection, rejection
and immunoreaction [2].
Bone tissue engineering (BTE) provides an interdisci-
plinary approach to promote the physiological regeneration
of bone tissues, overcoming the downfalls of current
methods. BTE research focuses on developing bioactive
scaffolds that, mimicking the bone structure, work as
temporary matrices for cell proliferation, extracellular
matrix deposition and vascularization of newly formed
tissue [3, 4]. In order to reach these targets, an ideal
scaffold for BTE applications should possess the following
properties: have a porous structure; be biocompatible; have
good mechanical properties to support tissue ingrowth; be
fully biodegradable; resorb while bone formation occurs,
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eliminating the need for a revision surgery; not form toxic
products; and finally deliver bioactive molecules or drugs
in a controlled manner where needed [5].
Among the possible scaffolds for tissue engineering,
hydrogels represent ideal systems due to their biocompati-
bility and biodegradability [6, 7]. These gels can be formu-
lated from different natural polymers such as collagen,
chitosan, fibrin, hyaluronic acid and alginate [8, 9]. Chitosan
is a linear polysaccharide derived from N-deacetylation of
chitin, which is commonly found in the exoskeletons of
crustaceans and insects [10]; its biocompatibility, antibac-
terial properties and structure amenable to simple chemical
modifications, make chitosan a very interesting polymer for
biomedical applications [11]. Chitosan only hydrogels pre-
sent poor bioactive and mechanical properties; however, we
have previously demonstrated that the combined addition of
hydroxyapatite (HA) and carbon nanotubes (CNTs) can
improve gels properties [12]. HA is a natural, nontoxic and
bioactive ceramic, shown to enhance osteoconduction, bone
bonding and stiffness in scaffolds. Moreover, HA favours
deposition of calcium phosphate, improving the bone-matrix
interface strength [13, 14]. CNTs are cylindrical molecules
of carbon atoms in sp2 conformation with outstanding
chemical, electrical, mechanical and thermal properties [15].
They have recently been shown to have a role in the differ-
entiation of osteoblasts suggesting that they might have a
double function in scaffolds for BTE as structural rein-
forcement and osteiniductive materials [16]. However, their
application is dependent on their successful dispersion in
physiological conditions. In fact, CNTs have a tendency to
form large bundles in aqueous media, resulting fromVan der
Waals interaction and p–p stacking [17–19]. Such bundles
may cause slippage between nanotubes, become stress con-
centrators or initiate cracks under applied forces. Many
covalent and non-covalent modifications of CNTs have been
proposed in order to increase their water dispersability and
hence their biocompatibility. Non-covalentmodifications, in
particular, are based on the absorption or the wrapping of
various functional molecules, such as biomolecules, poly-
mers, surfactants and phospholipids around the CNTs [20].
In a previous study, we have demonstrated the possibility of
efficiently stabilising single-walled carbon nanotubes with
the amphiphilic and self-assembling chitosan derivative N-
octyl-O-sulfate chitosan (NOSC) [21].
In the present study, we developed thermosensitive
chitosan hydrogels containing NOSC stabilised CNTs
(SWNTs or MWNTs). Our aim was to develop a more
flexible formulation strategy by using non-covalent CNTs
stabilisation instead of chemical grafting and studying the
effects of this strategy on the mechanical and physico-
chemical properties of the formulations. Image analysis
was used to qualitatively and quantitatively assess the
effect of CNTs on salts deposition within the formulated
hydrogels. The ability of the gel to provide a platform for
the controlled release of protein drugs was also evaluated.
2 Materials and methods
2.1 Materials
All salts and solvents, unless otherwise stated, were
obtained from Fisher Scientific (UK). Sodium phosphate
monobasic monohydrate, low viscosity chitosan from
shrimp, glycerol phosphate disodium salt hydrate, tris(hy-
droxymethyl)amino-methane [(HOCH2)3CNH2], albumin
from bovine serum (BSA), albumin from chicken egg
white (OVA) and QuantiProTM Bicinchoninic Acid Assay
Kit were obtained from Sigma-Aldrich (UK). L(?)-lactic
acid 90 % solution in water was obtained from Acros
Organics (USA). Dialysis membranes (size 10, MWCO
12–14 kDa) were obtained from Medicell International Ltd
(UK). MWCTs and SWCTs were purchased from Cheap
Tubes Inc. (USA). The MWCTs used in the study were
8–15 nm in diameter and 10–50 lm in length. The SWCTs
used were 1–4 nm in diameter and 5–30 lm in length. Di-
potassium hydrogen orthophosphate anhydrous (K2HPO4)
was acquired from British Drug Houses (UK) and tro-
closene sodium dehydrate from Guest Medical (UK).
Water used in all experiments was purified water. NOSC
and chitosan modified hydroxyapatite (HACS) were pre-
pared as described previously [12, 21].
2.2 Formulation of hydrogels
Clear solutions of chitosan were prepared by dissolving
chitosan (200 mg) in lactic acid (0.1 M, 7 ml), HACS
(86 mg) was then added and dispersed by vigorous mixing
and sonication. CNTs loaded formulations [CS-HACS-
(NOSC-SWNTs) and CS-HACS-(NOSC-MWNTs)] were
prepared by addition of stable CNTs suspensions in NOSC
(2 ml) to the HACS containing chitosan solutions. NOSC
suspensions of CNTs were obtained by adding CNTs
(2.5 mg) to a solution of NOSC (1.25 mg/ml) sonicating for
2 h, followed by overnight rest and further sonication for 1 h.
At this point all suspensions were brought to a final volume
of 9 ml by addition of lactic acid 0.1 M (if needed) and the
thermosenstive crosslinker glycerol phosphate was added
(1 ml, 1.12 g/ml) to all samples, which were then stirred for
10 min. Gelation was obtained by incubating the formula-
tions at 37 C. The gels prepared were labelled CS (chitosan
control gel), CS-HACS (chitosan gel containingHACS),CS-
HACS-(NOSC-SWNTs) and CS-HACS-(NOSC-MWNTs)
(gels containing HACS and SWNTs or MWNTs, respec-
tively). All gelswere prepared in triplicate; gelation timewas
evaluated visually by the inversion method [22].
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2.3 Texture analysis of the gels
A Texture Analyzer (XT plus, Stable Micro Systems Ltd,
UK) was used to determine syringeability of the suspen-
sions before gelation as well as gel compressibility. The
methods employed have been described previously by
Yasmeen et al. [12]. Briefly, for syringeability the liquid
formulations were loaded onto 5 ml plastic syringes fitted
with 19 G, 25 mm long needles. The vertically clamped
syringe was actioned by the instrument probe (10 mm
diameter) that compressed the barrel (1 mm/s) to a distance
of 40 mm and the initial glide force, dynamic glide force
and maximum force were measured. Compressibility tests
were performed by depressing a polycarbonate probe
(10 mm dia) into the gels at 1 mm/s up to a depth of 5 mm,
six measurements were taken before and after the sol–gel
transition took place. Gels were formed and tested in 14 ml
glass vials. Force/displacement curves were obtained and
used to calculate the gel compressibility (N•mm). All
measurements were performed at room temperature.
2.4 Characterisation of the freeze dried hydrogels
Freeze dried hydrogels were prepared from the suspension
described above and then transferred into 24 well-plates
(2 ml per well), before incubation at 37 C. Once formed,
the gels were flash-freezed and freeze-dried (Edwards
Micro Modulyo RV3, UK). The samples were character-
ized by FT-IR (Varian Spectrometer 640, UK), DVS
(Surface Measurement Systems DVS Advantage, UK) and
SEM (JEOL JSM-6060 LV Scanning Electron Microscope,
UK). In the DVS analysis the mass change of the gels
subjected to a changing water vapour partial pressure at
25 C was recorded. The partial pressure was increased
from 0 to 90 % at incremental steps of 10 %, where the
next step was reached either after equilibrium or after a
maximum time of 360 min. A full adsorption/desorption
cycle was performed and the data collected were used to
calculate the adsorption/desorption isotherms.
2.5 In vitro calcification assay
Calcification studies were performed to investigate the
ability of the composite hydrogels to induce calcium salts
deposition. Simulated body fluid (SBF), prepared accord-
ing to Kokubo and Takadama [23], was used to mimic the
in vivo environment, as it contains ions at very similar
concentrations to those of human blood plasma. The freeze
dried samples were inserted in a 50 ml tube to which 15 ml
of SBF were added. Samples were incubated at 37 C for 7
or 14 days. The SBF was changed every 4 days. Finally,
samples were dried under vacuum at 40 C overnight.
Controls were hydrated in deionised water for 5 h and
dried as above. All samples were gold-coated with sputter
coater (Polaron e500, Quoram Technologies, UK) and
analysed by SEM, coupled with EDS [Silicon Drift
Detector (SDD)—X-MaxN, Oxford Instruments, UK] and
microCT (XTH225, Nikon Systems, UK). The microCT
scanner was set to a voltage of 55 kV and a current of 75
lA. With an isotropic voxel size of 10.6 lm and exposure
of 2 s, the image acquisition was performed at a rotational
step of 0.23 over 360 for 90 min approximately. The
images were then analysed using ImageJ (1.48v, NIH,
USA) as described below. To quantify calcium deposition,
image thresholding (global) based on the grey scale his-
togram was carried out to distinguish between the different
material densities (different attenuation). Total volume of
the sample and total volume of the denser material in the
sample (i.e. the deposits of calcium salts) were obtained
and the percentage of calcium deposition was calculated
for each sample (n = 5). EDS images for calcium (Ca) and
phosphorus (P) were also analysed after being overlaid to
corresponding SEM images. The total area of overlapping
for Ca and P onto the total sample surface area was used to
calculate percentage of Ca and P salt deposition (n = 3).
2.6 Release of model drugs
Release studies were performed including bovine serum
albumin (BSA, 1 mg/ml) in the hydrogels (5 ml). After the
gelation of the samples, prepared in a 15 ml tubes (n = 4),
PBS (5 ml) was added. The samples were then incubated at
37 C and at set time points 2 ml of PBS were sampled and
replaced with 2 ml of fresh buffer. Release studies were also
performed including ovalbumin (OVA, 1 mg/ml) in the
hydrogels. The suspensions were transferred (1 g per sam-
ple) into a Flot-A-Lyzer G2 dialysis device (cut off 50 kDa)
and PBS (15 ml) was added to them. The samples were
subsequently incubated at 37 C and at set time points the
sampled buffer was replaced with fresh buffer. Determina-
tion of both BSA and OVA concentrations was carried out
with a QuantiProTM Bicinchoninic Acid Assay Kit (Sigma,
UK) and samples prepared according to manufacturer’s
instructions, reading the UV absorbance at 570 nm. Unloa-
ded gels were used as a control to eliminate any false
response due to chitosan interaction with the assay kit. The
two model drugs were tested with slightly different methods
due to limitations imposed by their molecular weight.
3 Results
3.1 Texture analysis of the thermosentive hydrogels
A chitosan only formulation was used as a control to
evaluate the effect of the addition of HACS and CNTs
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suspensions on the physical properties of gels before and
after formation. The chitosan only formulation underwent
sol–gel transition at 37 C in 60 min, whereas the addition
of HACS and NOSC suspensions of SWNTs and MWNTs
reduced this time to 7 and 9 min, respectively. The
syringeability of the suspensions was also studied. A force
of 30 N was considered as the maximum acceptable force
for an injection to be performed without particular patient
discomfort [24]; none of the samples tested presented
values above 10 N (Table 1) [25]. Furthermore, texture
analysis was performed to determine gel compressibility
(Fig. 1a).
All suspensions tested showed significant difference in
strength before and after gelation at 37 C (at least
P = 0.0004, two tailed, t test with Welch’s correction)
apart from the chitosan control. In particular, after gela-
tion the formulation containing SWNTs showed signifi-
cantly higher values compared to all other formulations
(0.273 ± 0.001 N mm).
3.2 Characterisation of the freeze dried hydrogels
The morphology of the freeze-dried hydrogels was evalu-
ated by SEM (Fig. 2). The chitosan only gel appeared to be
scaly and rough while the gels containing CNTs showed a
more defined porous structure with evidence of coated
CNTs filaments bridging the structure; this was previously
observed by Ormsby et al. who observed CNTs bridging
sub-micron voids and preventing pore coalescence [26].
Table 1 Syringeability of
composite formulations
Stiction (N) Plateau force (N) End capture (N)
Chitosan 8.36 ± 0.33 8.56 ± 0.29 8.92 ± 0.13
Chitosan-HACS 8.86 ± 0.39 8.56 ± 0.34 9.09 ± 0.34
Chitosan-HACS-(NOSC-SWNTs) 6.69 ± 0.25*** 6.40 ± 0.24*** 6.56 ± 0.21***
Chitosan-HACS-(NOSC-MWNTs) 7.03 ± 0.15*** 6.92 ± 0.15*** 7.15 ± 0.22***
Stiction, plateau force and end capture are expressed as mean ± SD (n = 3). One way ANOVA,
P\ 0.001; Tukey–Kramer multiple comparison test
*** P\ 0.001, compared to the chitosan control
Fig. 1 a Compressibility of the
different formulations before
(grey) and after (black) sol–gel
transition. Results are reported
as mean ± SD (n = 3). One
way ANOVA (a = 0.05) on the
values after gelation returned
P = 0.0131; Tukey’s multiple
comparisons test: *P\ 0.05,
compared to chitosan;
#P\ 0.05 compared to CS-
HACS. Water sorption and
desorption isotherms of the
freeze dried hydrogels:
b chitosan; c CS-HACS-
(NOSC-SWNTs); d CS-HACS-
(NOSC-MWNTs). Data are
presented as mean ± SD
(n = 3)
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3.2.1 Dynamic vapour sorption
DVS analysis was performed to evaluate the amount and
kinetics of water sorption of the hydrogels. Previous
work showed that the addition of chitosan grafted CNTs
to chitosan hydrogel significantly decreased the
hydrophilicity of the formulation [12]; this was not the
case when the added CNTs were non-covalently coated
with NOSC (Fig. 1b–d). Applying Korsmeyer–Peppas
model to the absorption versus time curves, the mecha-
nism of water penetration described by the value of
np[ 0.89 was determined to be super case-II transport
(Table 2). Hence, it seems that the dynamic swelling
behaviour of hydrogels is dependent on the contribution
of both the penetrant (water) diffusion and polymer
relaxation [27].
Fig. 2 SEM of chitosan, CS-HACS-(NOSC-SWNTs) and CS-HACS-(NOSC-MWNTs) freeze dried hydrogels. Arrows indicate coated carbon
nanotubes within the hydrogel matrix
Table 2 Kinetic parameter
values for water penetration in
freeze-dried hydrogels
np Kp R
2
CS control 1.67 ± 0.15 0.000369 ± 0.000314 0.968 ± 0.015
CS-HACS-(NOSC-SWNTs) 1.79 ± 0.23 0.000260 ± 0.000335 0.973 ± 0.016
CS-HACS-(NOSC-MWNTs) 1.65 ± 0.16 0.000461 ± 0.000298 0.983 ± 0.007
Data are reported as mean ± SD (n = 3)
J Mater Sci: Mater Med  (2016) 27:126 Page 5 of 10  126 
123
3.2.2 In vitro calcification studies
Bioactivity of a scaffold proposed for bone regeneration
can be evaluated by studying the calcium salts deposition
on its surface and internal structure [23, 28]. Samples were
soaked in SBF for 7 and 14 days, at 37 C, and superficial
Ca/P co-deposition was evaluated by EDS coupled SEM
(Fig. 3); deposition, in the whole volume, of a denser
material was also visualised and quantified by microCT.
The quantitative analysis of the EDS data (Fig. 4a)
revealed that no calcium-phosphate deposits were found in
the gels containing only chitosan, both at 7 and 14 days.
Samples containing CNTs also contained HACS, this
accounted for 3.06 ± 0.09 and 3.52 ± 0.18 % co-localised
Ca/P present at time zero, for gels containing SWNTs and
MWNTs respectively. Furthermore, the SEM images
(Fig. 3) showed that HACS was more homogeneously
distributed in the samples containing SWNTs. In both
samples an increase in the concentration of co-localised Ca
and P was observed, with significantly higher values for the
gel containing SWNTs (7.8 ± 0.1 %). Further analysis of
areas characterised by Ca/P co-localisation revealed that
the Ca/P ratio of the newly formed deposits was 1.55
(Table 3) for gels containing MWNTs, this corresponds to
calcium deficient HA. Gels containing SWNTs presented
deposits with Ca/P ratio\1.50, suggesting a combination
of crystal phases of lower Ca/P values such as monetite,
brushite and octacalcium phosphate.
Salts deposition was also observed by micro CT
(Fig. 4b), were volumes of denser material were identified
and quantified, these may represent the deposition of other
salts as well as calcium phosphate salts that possess similar
x-ray attenuations. The micro CT analysis evidenced dif-
ferences in the microarchitecture of the hydrogel, were
chitosan alone gels presented a less homogenous and more
porous structure (Fig. 5). This may be attributed to the
Fig. 3 Overlay images of SEM pictures with EDS data: Ca (green), P (red) and co-localisation of Ca/P (yellow) (Color figure online)
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drying process, during which the migration of water from
the core to the periphery of the gel might have dragged the
chitosan to condense on the edge leaving a porous structure
in the core. This phenomenon is much less noticeable in the
gels containing CNTs, confirming how CNTs have an
important role in the formation and preservation of the 3D
gel structure. As a consequence, a marked difference in the
distribution of the salts deposition was observed and
resulted in a much more homogeneous distribution in gels
containing CNTs. Quantitative analysis (Fig. 4b) also
revealed a higher deposition of salts in CNTs containing
gels, with no significant difference between SWNTs and
MWNTs (34.6 ± 2.6 and 36.0 ± 1.1 % salt deposition
over total sample volume, respectively) [29]. These data
are in good agreement with the EDS/SEM data and confirm
that calcification is notably more pronounced in samples
containing HACS and CNTs.
3.3 Release of model drugs
The release of two macromolecular model drugs, albumin
form chicken egg (OVA, Mw 45 kDa, Fig. 4c) and bovine
serum albumin (BSA, Mw 66 kDa, Fig. 4d), were studied
for 14 days. All the hydrogels tested showed the potential
to provide controlled release within the 2 weeks of the
experiment. Analysis of the release during the first 5 h
revealed very similar release profiles for all gels, indicating
that the initial release is governed by the behavior of the
chitosan component of the gel. The addition of HACS and
CNTs decreased the amount of BSA release over 14 days,
but this did not have a significant effect on the release of
Fig. 4 a Quantitative analysis of surface calcium deposition present-
ing % of surface covered by co-localised Ca and P (from SEM). Data
are reported as mean ± SD (n = 3). One-way ANOVA (a = 0.05)
P\ 0.0001 for both gels containing CNTs; Tukey’s multicomparison
test, ***P\ 0.001 compared to control at time zero, ###P\ 0.001
compared to a specific sample as indicated in the figure. b Average %
salt deposition on different types of hydrogel samples (from
microCT). Data are reported as mean ± SD (n = 5). One-way
ANOVA (a = 0.05) P\ 0.0001 for both gels containing CNTs,
Tukey’s multicomparison test, all samples presented P\ 0.001
compared to control, and P\ 0.001 was obtained for all comparisons
between 7 and 14 days. Release profile of c BSA d OVA from (black
closed circle) chitosan; (red closed square) CS-HACS-(NOSC-
SWNTs); (blue closed triangle) CS-HACS-(NOSC-MWNTs) gels.
Data are reported as mean ± SD (n = 3) (Color figure online)
Table 3 Ca/P ratio of salt deposits on hydrogels incubated with SBF
for 7 and 14 days, t-test (paired, two-tailed)
7 days 14 days
CS-HACS-(NOSC-SWNTs) 1.45 ± 0.54 1.32 ± 0.04
CS-HACS-(NOSC-MWNTs) 1.55 ± 0.30 1.55 ± 0.15*
* P\ 0.05, compared to the HACS included in the gels which had a
Ca/P ratio of 1.34 ± 0.06
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OVA. This suggests that the mechanism of release for
OVA is mainly dependent on the interaction of the protein
with the chitosan network. Also gel degradation has an
effect, indeed a marked change in the gel structure was
noticed after 14 days of BSA release study. Hydrogels
before the release study presented a typical porous struc-
ture, with well-defined pores of different size; while
hydrogels after the release presented a scaly appearance.
4 Discussion
Composite thermosensitive chitosan hydrogels were for-
mulated. The addition of CNTs was confirmed to have a
significant effect on the sol–gel transition time; these
results are in accordance to those obtained by addition of
chitosan grafted CNTs [12], indicating that both covalently
and non-covalently coated CNTs present similar thermal
behaviour and lead to similar effects on the gelation time of
the formulations [30, 31]. Unexpectedly, the formulations
containing NOSC suspensions of CNTs had better
syringeability performance than chitosan only or chitosan
with HACS formulation, while previous studies showed
that the addition of chitosan grafted CNTs increased the
force needed to expel the suspension from the syringe [12].
These data show that covalent and non-covalent coating of
CNTs can have very different effect on the viscosity of the
suspensions and their syringeability. In our previous work,
we demonstrated that NOSC tends to stretch and align
along the surface of CNTs [32], reducing the opportunity
Fig. 5 Representative micro CT slices of different gel samples incubated in SBF for 0, 7 and 14 days
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for formation of physical entanglements between NOSC
and the free chitosan chains present in the gel. It is pos-
tulated that under the shear stress applied during injection
non-covalently coated CNTs are able to align within the
flowing liquid formulation therefore present a reduced
resistance compared to a crosslinked system. Conversely,
CNTs afforded a significant increase in resistance to
compression for the composite hydrogels. In comparison
with published data, where chitosan grafted CNTs were
added instead of non-covalently coated ones, no statistical
difference was noticed in the hydrogels containing
MWNTs, while SWNTs produced statistically stronger
gels (P\ 0.05) when suspended in NOSC solutions [12].
The use of NOSC for the stabilisation of CNTs reduced the
hydrophobicity of the nanotubes when compared to chi-
tosan grafted CNTs. This phenomenon can be explained by
considering the shielding effect that NOSC has on the
surface of the nanotubes. In fact, five chains of NOSC
arrange themselves along the entire surface of CNTs, thus
resulting in a net decrease of surface hydrophobicity [21].
Reduced hydrophobicity has been linked with better
in vivo outcomes [26, 33, 34]; furthermore, previous
studies demonstrated the cytocompatibility of CNTs sta-
bilised in NOSC (data not shown). The in vitro calcification
studies revealed that CNTs played a major role in the
spatial arrangements of newly formed calcium deposits in
the composite materials studied, suggesting that they may
have a role in the way the repair of fragile and/or fractured
bones occurs in vivo. Finally, in model drug delivery
studies, the composite gels demonstrated potential as
delivery platforms for macromolecular drugs with mini-
mum interference by CNTs in the determination of the
mechanism of drug release.
In conclusion the present study reports of a simple non-
covalent method for the inclusion of CNTs into hydrophilic
chitosan hydrogels. The non-covalent stabilisation of the
nanotubes is advantageous as it facilitates the injectability
of the formulation while affording gels with higher com-
pressibility. CNTs also proved to be key in guaranteeing a
homogeneous deposition of salts suggesting that they can
be used for guided mineralisation of scaffold for bone
regeneration. Finally the gels have potential also as plat-
forms for prolonged drug delivery.
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